Magto, Rufina .
HRN: 11-47-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/24/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/24/2024
12/31/2024
IV
4.5
Q8
Decubitus Ulcer
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes